SignalCorporate

Pulmonx reiterates $90M-$92M 2026 revenue outlook while guiding to $108M-$109M operating expenses

Pulmonx reaffirmed $90M–$92M 2026 revenue guidance alongside $108M–$109M operating expense outlook.

Context

What happened: Pulmonx reported Q3 2026 worldwide revenue of $22.8 million and reiterated its full-year 2026 revenue outlook while guiding to operating expenses. Key numbers: Q3 2026 revenue $22.8 million. 2026 revenue outlook $90M-$92M. 2026 operating expenses $108M-$109M. Why it matters: Management framed the quarter as a return to year-over-year growth, with the CEO citing the revenue result as the organization's return.

What changed

Pulmonx reported Q3 2026 worldwide revenue of $22.8 million and reiterated its full-year 2026 revenue outlook while guiding to operating expenses.

Why it matters

Management framed the quarter as a return to year-over-year growth, with the CEO citing the revenue result as the organization's return.

Sources

seekingalpha